Alemtuzumab-induced immune-mediated thrombotic thrombocytopenic purpura: A newly described drug-related autoimmune disease.

MLA

Bourdin, V., et al. “Alemtuzumab-Induced Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Newly Described Drug-Related Autoimmune Disease.” British Journal of Haematology, vol. 204, no. 4, Apr. 2024, pp. 1459–63. EBSCOhost, https://doi.org/10.1111/bjh.19263.

APA

Bourdin, V., Fossé, Q., Lambotte, O., Joly, B., Coppo, P., Anguel, N., & Labeyrie, C. (2024). Alemtuzumab-induced immune-mediated thrombotic thrombocytopenic purpura: A newly described drug-related autoimmune disease. British Journal of Haematology, 204(4), 1459–1463. https://doi.org/10.1111/bjh.19263

Chicago

Bourdin, V, Q Fossé, O Lambotte, B Joly, P Coppo, N Anguel, and C Labeyrie. 2024. “Alemtuzumab-Induced Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Newly Described Drug-Related Autoimmune Disease.” British Journal of Haematology 204 (4): 1459–63. doi:10.1111/bjh.19263.